Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Completed Phase 1 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0029856 (Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs